Human GRIN2B variants in neurodevelopmental disorders

Journal of Pharmacological Sciences

Volumn 132, Issue 2, 2016, Pages 115-121

  Hu, Chun ^a   Chen, Wenjuan ^a   Myers, Scott J ^a   Yuan, Hongjie ^a   Traynelis, Stephen F ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Developmental delay; GluN2B NR2B; Intellectual disability; Neuropsychiatric disorders; NMDA receptor

Indexed keywords

AMINO ACID; CELL PROTEIN; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PDZ PROTEIN; SCAFFOLD PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR2B NMDA RECEPTOR;

AMINO TERMINAL SEQUENCE; ATTENTION DEFICIT DISORDER; AUTISM; CARBOXY TERMINAL SEQUENCE; CHILDHOOD DISEASE; CHROMOSOME TRANSLOCATION; DEVELOPMENTAL DISORDER; EPILEPSY; FRAMESHIFT MUTATION; GENE; GENE NUMBER; GENETIC CODE; GENETIC VARIABILITY; GRIN2B GENE; HUMAN; INTELLECTUAL IMPAIRMENT; LANGUAGE DISABILITY; LEARNING DISORDER; MENTAL DISEASE; MOTOR DYSFUNCTION; MULTIGENE FAMILY; MUTATIONAL ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SCHIZOPHRENIA; AUTISM SPECTRUM DISORDER; CHEMISTRY; GENETIC VARIATION; GENETICS; NEURODEVELOPMENTAL DISORDERS; PROTEIN SECONDARY STRUCTURE;

AUTISM SPECTRUM DISORDER; GENETIC VARIATION; HUMANS; NEURODEVELOPMENTAL DISORDERS; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84994495783     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1016/j.jphs.2016.10.002     Document Type: Review

References (56)

1. (1) Akazawa, C., Shigemoto, R., Bessho, Y., Nakanishi, S., Mizuno, N., Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats. J Comp Neurol 347 (1994), 150–160.
2. (2) Monyer, H., Burnashev, N., Laurie, D.J., Sakmann, B., Seeburg, P.H., Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:3 (1994), 529–540.
3. (3) Cohen, S., Greenberg, M.E., Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Annu Rev Cell Dev Biol 24 (2008), 183–209.
4. (4) Hall, B.J., Ripley, B., Ghosh, A., NR2B signaling regulates the development of synaptic AMPA receptor current. J Neurosci 27:49 (2007), 13446–13456.
5. (5) Kutsuwada, T., Sakimura, K., Manabe, T., Takayama, C., Katakura, N., Kushiya, E., et al. Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron 16 (1996), 333–344.
6. (6) Tang, Y.P., Shimizu, E., Dube, G.R., Rampon, C., Kerchner, G a, Zhuo, M., et al. Genetic enhancement of learning and memory in mice. Nature 401:6748 (1999), 63–69.
7. (7) Endele, S., Rosenberger, G., Geider, K., Popp, B., Tamer, C., Stefanova, I., et al. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 42:11 (2010), 1021–1026.
8. (8) Reutlinger, C., Helbig, I., Gawelczyk, B., Subero, J.I., Tönnies, H., Muhle, H., et al. Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region. Epilepsia 51:9 (2015), 1870–1873.
9. (9) de Ligt, J., Willemsen, M.H., van Bon, B.W.M., Kleefstra, T., Yntema, H.G., Kroes, T., et al. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 367 (2012), 1921–1929.
10. (10) Hamdan, F.F., Srour, M., Capo-Chichi, J.M., Daoud, H., Nassif, C., Patry, L., et al. De novo mutations in moderate or severe intellectual disability. PLoS Genet, 10(10), 2014, e1004772.
11. (11) Bosch, D.G., Boonstra, F.N., de Leeuw, N., Pfundt, R., Nillesen, W.M., de Ligt, J., et al. Novel genetic causes for cerebral visual impairment. Eur J Hum Genet 24:5 (2016), 660–665.
12. (12) Lelieveld, S.H., Reijnders, M.R., Pfundt, R., Yntema, H.G., Kamsteeg, E.J., de Vries, P., et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nat Neurosci 19:9 (2016), 1194–1196.
13. (13) Lemke, J.R., Hendrickx, R., Geider, K., Laube, B., Schwake, M., Harvey, R.J., et al. GRIN2B mutations in west syndrome and intellectual disability with focal epilepsy. Ann Neurol 75:1 (2014), 147–154.
14. (14) Rauch, A., Wieczorek, D., Graf, E., Wieland, T., Endele, S., Schwarzmayr, T., et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 380:9854 (2012), 1674–1682.
15. (15) Zhang, Y., Kong, W., Gao, Y., Liu, X., Gao, K., Xie, H., et al. Gene mutation analysis in 253 Chinese children with unexplained epilepsy and intellectual/developmental disabilities. PLoS One, 10(11), 2015, e0141782.
16. (16) Allen, A.S., Berkovic, S.F., Cossette, P., Delanty, N., Dlugos, D., Eichler, E.E., et al. De novo mutations in epileptic encephalopathies. Nature 501:7466 (2013), 217–221.
17. (17) McRae, J.F., Clayton, S., Fitzgerald, T.W., Kaplanis, J., Prigmore, E., et al. Prevalence, phenotype and architecture of developmental disorders caused by de novo mutation. bioRxiv, 2016, 10.1101/049056.
18. (18) Talkowski, M.E., Rosenfeld, J.A., Blumenthal, I., Pillalamarri, V., Chiang, C., Heilbut, A., et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 149:3 (2012), 525–537.
19. (19) Awadalla, P., Gauthier, J., Myers, R.A., Casals, F., Hamdan, F.F., et al. Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet 87:3 (2010), 316–324.
20. (20) Kenny, E.M., Cormican, P., Furlong, S., Heron, E., Kenny, G., Fahey, C., et al. Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders. Mol Psychiatry 19:8 (2014), 872–879.
21. (21) Yavarna, T., Al-Dewik, N., Al-Mureikhi, M., Ali, R., Al-Mesaifri, F., et al. High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders. Hum Genet 134 (2015), 967–980.
22. (22) O'Roak, B.J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B.P., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485:7397 (2012), 246–250.
23. (23) O'Roak, B.J., Deriziotis, P., Lee, C., Vives, L., Schwartz, J.J., Girirajan, S., et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 43:6 (2011), 585–589.
24. (24) O'Roak, B.J., Vives, L., Fu, W., Egertson, J.D., Stanaway, I.B., Phelps, I.G., et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders brain. Science, 338, 2012, 1619.
25. (25) Pan, Y., Chen, J., Guo, H., Ou, J., Peng, Y., Liu, Q., et al. Association of genetic variants of GRIN2B with autism. Sci Rep(5), 2015, 8296.
26. (26) Tarabeux, J., Kebir, O., Gauthier, J., Hamdan, F.F., Xiong, L., Piton, A., et al. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. Transl Psychiatry, 1, 2011, e55.
27. (27) Williams, H.J., Georgieva, L., Dwyer, S., Kirov, G., Owen, M.J., O'Donovan, M.C., Absence of de novo point mutations in exons of GRIN2B in a large schizophrenia trio sample. Schizophr Res 141:2–3 (2012), 274–276.
28. (28) Andreoli, V., De Marco, E.V., Trecroci, F., Cittadella, R., Di Palma, G., Gambardella, A., Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer's disease. J Neural Transm (Vienna) 121:5 (2014), 533–542.
29. (29) Freunscht, I., Popp, B., Blank, R., Endele, S., Moog, U., Petri, H., et al. Behavioral phenotype in five individuals with de novo mutations within the GRIN2B gene. Behav Brain Funct, 9, 2013, 20.
30. (30) Dimassi, S., Andrieux, J., Labalme, A., Lesca, G., Cordier, M.P., Boute, O., et al. Interstitial 12p13.1 deletion involving GRIN2B in three patients with intellectual disability. Am J Med Genet Part A 116A (2013), 2564–2569.
31. (31) Poirsier, C., Landais, E., Bednarek, N., Nobecourt, J.M., Khoury, M., Schmidt, P., et al. Report on 3 patients with 12p duplication including GRIN2B. Eur J Med Genet 57:5 (2014), 185–194.
32. (32) Traynelis, S.F., Wollmuth, L.P., McBain, C.J., Menniti, F.S., Vance, K.M., Ogden, K.K., et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62:3 (2010), 405–496.
33. (33) Stroebel, D., Buhl, D.L., Knafels, J.D., Chanda, P.K., Green, M., Sciabola, S., et al. A novel binding mode reveals two distinct classes of NMDA receptor GluN2B-selective antagonists. Mol Pharmacol 89:5 (2016), 541–551.
34. (34) Adams, D.R., Yuan, H., Holyoak, T., Arajs, K.H., Hakimi, P., Markello, T.C., et al. Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity. Mol Genet Metab 113:3 (2014), 161–170.
35. (35) Lek, M., Karczewski, K.J., Minikel, E.V., Samocha, K.E., Banks, E., Fennell, T., et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:7616 (2016), 285–291.
36. (36) Sobolevsky, A.I., Rosconi, M.P., Gouaux, E., X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 462 (2009), 745–756.
37. (37) Karakas, E., Furukawa, H., Crystal structure of a heterotetrameric NMDA receptor ion channel. Science 344 (2014), 992–997.
38. (38) Lee, C.-H., Lü, W., Michel, J.C., Goehring, A., Du, J., Song, X., et al. NMDA receptor structures reveal subunit arrangement and pore architecture. Nature 511 (2014), 191–197.
39. (39) Hawkins, L.M., Prybylowski, K., Chang, K., Moussan, C., Stephenson, F.A., Wenthold, R.J., Export from the endoplasmic reticulum of assembled N-methyl-D-aspartic acid receptors is controlled by a motif in the C terminus of the NR2 subunit. J Biol Chem 279:28 (2004), 28903–28910.
40. (40) Jo, K., Derin, R., Li, M., Bredt, D.S., Characterization of MALS/Velis-1, -2, and -3: a family of mammalian LIN-7 homologs enriched at brain synapses in association with the postsynaptic density-95/NMDA receptor postsynaptic complex. J Neurosci 19:11 (1999), 4189–4199.
41. (41) Kornau, H.-C., Schenker, L.T., Kennedy, M.B., Seeburg, P.H., Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Source Sci New Ser 269:5231 (1995), 1737–1740.
42. (42) Niethammer, M., Kim, E., Sheng, M., Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. J Neurosci 16:7 (1996), 2157–2163.
43. (43) Müller, B.M., Kistner, U., Kindler, S., Chung, W.J., Kuhlendahl, S., Fenster, S.D., et al. SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo. Neuron 17:2 (1996), 255–265.
44. (44) Sans, N., Prybylowski, K., Petralia, R.S., Chang, K., Wang, Y.-X., Racca, C., et al. NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex. Nat Cell Biol 5:6 (2003), 520–530.
45. (45) Wyszynski, M., Lin, J., Rao, A., Nigh, E., Beggs, A.H., Craig, A.M., et al. Competitive binding of ?-actinin and calmodulin to the NMDA receptor. Nature 385:6615 (1997), 439–442.
46. (46) Yaka, R., Thornton, C., Vagts, A.J., Phamluong, K., Bonci, A., Ron, D., NMDA receptor function is regulated by the inhibitory scaffolding protein, RACK1. Proc Natl Acad Sci USA 99:8 (2002), 5710–5715.
47. (47) Lavezzari, G., Subunit-specific regulation of NMDA receptor endocytosis. J Neurosci 24:28 (2004), 6383–6391.
48. (48) Prybylowski, K., Chang, K., Sans, N., Kan, L., Vicini, S., Wenthold, R.J., The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron 47:6 (2005), 845–857.
49. (49) Petrovski, S., Wang, Q., Heinzen, E.L., Allen, A.S., Goldstein, D.B., Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet, 9(8), 2013, e1003709.
50. (50) EpiPM Consortium, A roadmap for precision medicine in the epilepsies. Lancet Neurol 14:12 (2015), 1219–1228.
51. (51) Taylor, D.L., Tiwari, A.K., Lieberman, J.A., Potkin, S.G., Meltzer, H.Y., Knight, J., et al. Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine. Hum Psychopharmacol Clin Exp 31 (2016), 121–134.
52. (52) Masuko, T., Kuno, T., Kashiwagi, K., Kusama, T., Williams, K., Igarashi, K., Stimulatory and inhibitory properties of aminoglycoside antibiotics at N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 290:3 (1999), 1026–1033.
53. (53) Zhu, X., Petrovski, S., Xie, P., Ruzzo, E.K., Lu, Y.F., McSweeney, K.M., et al. Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genet Med 17:10 (2015), 774–781.
54. (54) Swanger, S.A., Chen, W., Wells, G., Burger, P.B., Tankovic, A., et al. Mechanistic insight into NMDA receptor dysregulation by rare variants in the GluN2A and GluN2B agonist binding domains. Amer J Hum Gen, 2016 in press.
55. (55) Burnashev, N., Szepetowski, P., NMDA receptor subunit mutations in neurodevelopmental disorders. Curr Opin Pharmacol 20 (2015), 73–82, 10.1016/j.coph.2014.11.008.
56. (56) Soto, D., Altafaj, X., Sindreu, C., Bayés, Á., Glutamate receptor mutations in psychiatric and neurodevelopmental disorders. Commun Integr Biol, 7(1), 2014, e27887.